These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 17216026)

  • 1. Progress towards the easier use of P450 enzymes.
    Chefson A; Auclair K
    Mol Biosyst; 2006 Oct; 2(10):462-9. PubMed ID: 17216026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
    Urlacher VB; Schmid RD
    Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
    [No Abstract]   [Full Text] [Related]  

  • 3. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties.
    Fasan R; Chen MM; Crook NC; Arnold FH
    Angew Chem Int Ed Engl; 2007; 46(44):8414-8. PubMed ID: 17886313
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparative use of isolated CYP102 monooxygenases -- a critical appraisal.
    Eiben S; Kaysser L; Maurer S; Kühnel K; Urlacher VB; Schmid RD
    J Biotechnol; 2006 Aug; 124(4):662-9. PubMed ID: 16716428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformations using prokaryotic P450 monooxygenases.
    Urlacher V; Schmid RD
    Curr Opin Biotechnol; 2002 Dec; 13(6):557-64. PubMed ID: 12482514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
    Peters MW; Meinhold P; Glieder A; Arnold FH
    J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving catalytic properties of P450 BM3 haem domain electrodes by molecular Lego.
    Fantuzzi A; Meharenna YT; Briscoe PB; Sassone C; Borgia B; Gilardi G
    Chem Commun (Camb); 2006 Mar; (12):1289-91. PubMed ID: 16538250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms.
    Lüdemann SK; Lounnas V; Wade RC
    J Mol Biol; 2000 Nov; 303(5):797-811. PubMed ID: 11061976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
    Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
    Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory evolution of cytochrome p450 BM-3 monooxygenase for organic cosolvents.
    Wong TS; Arnold FH; Schwaneberg U
    Biotechnol Bioeng; 2004 Feb; 85(3):351-8. PubMed ID: 14748091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering cytochrome P450 enzymes for improved activity towards biomimetic 1,4-NADH cofactors.
    Ryan JD; Fish RH; Clark DS
    Chembiochem; 2008 Nov; 9(16):2579-82. PubMed ID: 18816544
    [No Abstract]   [Full Text] [Related]  

  • 13. Evolved CYP102A1 (P450BM3) variants oxidise a range of non-natural substrates and offer new selectivity options.
    Whitehouse CJ; Bell SG; Tufton HG; Kenny RJ; Ogilvie LC; Wong LL
    Chem Commun (Camb); 2008 Feb; (8):966-8. PubMed ID: 18283351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective hydroxylation of an achiral cyclopentanecarboxylic acid derivative using engineered P450s BM-3.
    Münzer DF; Meinhold P; Peters MW; Feichtenhofer S; Griengl H; Arnold FH; Glieder A; de Raadt A
    Chem Commun (Camb); 2005 May; (20):2597-9. PubMed ID: 15900339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of substrates at the surface of P450s can greatly enhance substrate potency.
    Hegde A; Haines DC; Bondlela M; Chen B; Schaffer N; Tomchick DR; Machius M; Nguyen H; Chowdhary PK; Stewart L; Lopez C; Peterson JA
    Biochemistry; 2007 Dec; 46(49):14010-7. PubMed ID: 18004886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
    Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
    Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P450 fingerprinting method for rapid discovery of terpene hydroxylating P450 catalysts with diversified regioselectivity.
    Zhang K; El Damaty S; Fasan R
    J Am Chem Soc; 2011 Mar; 133(10):3242-5. PubMed ID: 21341707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are branched chain fatty acids the natural substrates for P450(BM3)?
    Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
    Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altering the regioselectivity of cytochrome P450 CYP102A3 of Bacillus subtilis by using a new versatile assay system.
    Lentz O; Feenstra A; Habicher T; Hauer B; Schmid RD; Urlacher VB
    Chembiochem; 2006 Feb; 7(2):345-50. PubMed ID: 16381045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.